Skip to content
  • Home
  • About Us
  • Why
  • Program
  • Facility
  • Spotlight
    • Upcoming Events
    • Latest News
  • Admission
  • EN
    • ID
  • Home
  • About Us
  • Why
  • Program
  • Facility
  • Spotlight
    • Upcoming Events
    • Latest News
  • Admission
  • EN
    • ID

Dr. Apt. Ratnaningrum Dewi Karuna, S.Si., M.Sc.

WoS-Researcher ID: F-3653-2011
ORCID: 0000-0003-0508-2490
Scopus author: 25930021500
Google scholar: 145aYdkAAAAJ
H index scopus: 13
H index Google scholar: 14

 

Dr. Ratna Karuna brings over two decades of experience in successfully integrating academic research excellence with innovative industry leadership. As an industrial scientist in the field of Translational R&D, she plays a pivotal role in transforming fundamental scientific discoveries into impactful, market-ready products. Her career spans strategic roles in leading organizations such as Novartis (Switzerland and Singapore) and A*STAR, and she has served in top-level management as Head of the R&D Department at a biotechnology company in Singapore. Her expertise covers a wide spectrum of product development and regulatory affairs, with hands-on experience working with major regulatory bodies including the U.S. FDA, the European Medicines Agency (EMA), and Health Canada. She also has extensive experience in implementing Quality Management Systems (QMS) and has led testing laboratories toward achieving GLP (Good Laboratory Practice) and ISO 15189 / 17025 accreditations. In product development, she is skilled in evaluating Technology Readiness Levels, applying Quality by Design (QbD) approaches, and is recognized as a CMC (Chemistry, Manufacturing and Controls) expert within the GMP (Good Manufacturing Practice) framework for biotechnology products.

 

Dr. Ratna Karuna possesses deep expertise in instrumental analysis, particularly mass spectrometry (LC-MS/MS), with proficiency in a wide range of techniques including innovative method development and validation. Her expertise is applied across various areas such as metabolism and disposition studies of chemical compounds in the body, preclinical testing (pharmacology and toxicology), biomarker analysis, and biotechnology (bioprocessing). Her scientific contributions are reflected in 14 Scopus-indexed publications, including in high-impact journals such as Nature (impact factor 50.5) and Science Translational Medicine (impact factor 15.8).

 

Pendidikan:

  • Ph.D., Department of Chemistry and Applied Biosciences, The Swiss Federal Institute of Technology in Zurich (ETH Zurich), Swiss (2010)
  • M.Sc., Division of Analytical Biosciences, Leiden University, Belanda (2004)
  • Pharmacist (Apt.), Professional Apothecary Program, Faculty of Pharmacy, Airlangga University (2000)
  • Bachelor of Science (B.Sc.), Faculty of Pharmacy, Airlangga University (1999)

 

Bidang Keahlian:

  • Instrumental Analysis
  • Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS) and High-Resolution Mass Spectrometry (HRMS)
  • Metabolomics
  • Preclinical Testing
  • Biotechnology

 

Pengalaman Praktisi:

  • Head of R&D and Project Management Lead, Prestige BioPharma Ltd. Singapura (2021-2024)
  • Group Leader dan Principal Scientist, Agency for Science, Technology and Research (A*STAR) Singapura (2017-2021)
  • Lab Head Bioanalysis dan Principal Scientist, Novartis Institute for Tropical Diseases (NITD) Singapura (2012-2017)
  • Scientist, Analytical Science and Imaging Platform, Novartis Institutes for BioMedical Research (NIBR) Swiss (2010-2011)
  • Research Assistant, Division of Analytical Biosciences dan Division of Pharmacology, Leiden University, Belanda (2003-2005)

 

Awards:

  • Novartis Recognition Globally Awards (2012-2016)
  • Wilhelm-Simon Fellowship, Center of Excellence in Analytical Chemistry (CEAC), Switzerland (2006)
  • Huygens scholarship, Nuffic – Netherlands Organization for International Cooperation in Higher Education (2002)
  • Delta scholarship, Nuffic (2001)
Loading...
Research
May 6, 2025

A Cyclic Phosphoramidate Prodrug of 2′-Deoxy-2′-Fluoro-2′-C-Methylguanosine for the Treatment of Dengue Virus Infection

May 6, 2025

A head-to-head comparison of the inhibitory activities of 15 peptidomimetic SARS-CoV-2 3CLpro inhibitors

May 6, 2025

NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models

May 6, 2025

Discovery of Potent Non-Nucleoside Inhibitors of Dengue Viral RNA-Dependent RNA Polymerase from a Fragment Hit Using Structure-Based Drug Design

May 6, 2025

Discovery of Dengue Virus NS4B Inhibitors

Scholarship

As the world's leading Christian University, UK Petra is committed to nurturing the nation's future generations from all walks of life.

Pelajari Lebih Lanjut

Frequently Asked Questions

From financial obligations to international student requirements, you can find the questions below.

Learn more
Instagram Facebook Youtube Tiktok
Address

Jl. Siwalankerto No.121-131, Siwalankerto, Kec. Wonocolo, Kota SBY, Jawa Timur 60236

Contact

T: +62 31 8494830,
+62 31 8494831,
+62 31 8439040,
+62 31 2983000

E: [email protected]

WA Teknologi Pangan PCU :

+62 819-2928-8880

Important link
  • Petra e-Journal
  • Pusat Karir
  • Perpustakaan Digital
  • Petra e-Journal
  • Pusat Karir
  • Perpustakaan Digital

Copyright © 2023 Petra Christian University. All rights reserved.